Aditxt announced that it will effect a 1-for-40 reverse split of its common stock. Commencing with the opening of trading on the Nasdaq Capital Market on October 2, 2024, the Company’s common stock will trade on a post-split basis under the same symbol ADTX. The reverse stock split was approved by the Company’s stockholders at the annual meeting held on August 7, 2024, with the final ratio determined by the Company’s board of directors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX:
- Evofem Biosciences files proxy for stockholder approval of acquisition by Aditxt
- Aditxt, Inc. Outlines Growth Strategies at Global Investment Conference
- Aditxt, Evofem enter second amendment to plan of merger
- Aditxt files to sell $150M of common stock for holders
- Aditxt sells 1.13M shares at $1.06 in registered direct offering